How Standardized Is Transcranial Magnetic Stimulation Treatment for Depression? Large-Cohort Modeling Reveals Systematic Dosimetric Variability
Authors:
- Bella Bingbing ZhangBZBella Bingbing Zhang
- Tim Tianze LinTLTim Tianze Lin
- Penny Ping QinPQPenny Ping Qin
- Rebecca Laidi KanRKRebecca Laidi Kan
- Adam Weili XiaAXAdam Weili Xia
- Minxia JinMJMinxia Jin
- Yinghu PengYPYinghu Peng
- Daniel KeeserDKDaniel Keeser
- Frank PadbergFPFrank Padberg
- Martin TikMTMartin Tik
- Tifei YuanTYTifei Yuan
- Benjamin BeckerBBBenjamin Becker
Open Access
- 8 June 2026
- journal article
- research article
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- p. 1-17
Abstract
Introduction: Repetitive transcranial magnetic stimulation (rTMS) is a widely utilized, noninvasive brain stimulation technique for treating neurological and psychiatric disorders worldwide. The efficacy of rTMS is influenced by individual head morphology, which shapes the induced electric field (E-field) in the brain. The standard practice for dosing rTMS involves adjusting the intensity to a defined percentage of the motor threshold (MT), a method exemplified by the globally adopted, US FDA-approved protocol of using 120% MT for depression. Since head morphology varies systematically across ethnic groups, current dosing protocols may lead to inconsistent cortical dosing. Methods: Here, we used large-scale computational modeling (N = 1,085) to systematically evaluate TMS dosage across “White,” “Han Chinese,” and “Black or African Am.” populations. Results: Our findings reveal striking ethnic disparities in the E-field ratio between the therapeutic target (left dorsolateral prefrontal cortex, DLPFC) and the calibration site (left primary motor cortex, M1). “Han Chinese” individuals exhibited a significantly higher E-field ratio (E-fieldDLPFC/E-fieldM1 = 1.226) compared to “White” individuals (E-fieldDLPFC/E-fieldM1 = 1.096). These differences are primarily driven by variations in scalp-to-cortex distance (SCD). Based on these findings, we derived both simplified population-level adjustment formulas and individualized SCD-based dosing equations and implemented them in a web-based tool for practical use. Conclusion: Our results suggest that applying a uniform multiplier of MT to DLPFC stimulation may introduce systematic differences in delivered cortical dose across ethnic populations, highlighting that universal dosing conventions derived predominantly from specific demographic cohorts may embed bias, such that established safety and efficacy profiles may not be uniformly applicable across diverse global populations.Keywords
This publication has 98 references indexed in Scilit:
- Neuronavigation‐Guided rTMS for the Treatment of Depressive Patients With Suicidal Ideation: A Double‐Blind, Randomized, Sham‐Controlled TrialClinical Pharmacology & Therapeutics, 2020
- Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US VeteransJAMA Psychiatry, 2018
- Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive EpisodesJAMA Psychiatry, 2017
- Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trialWorld Psychiatry, 2015
- The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double‐blind, placebo‐controlled studyMovement Disorders, 2010
- Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive DisorderArchives of General Psychiatry, 2010
- Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2009
- Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulationDepression and Anxiety, 2004
- Transcranial Magnetic Stimulation in the Treatment of DepressionArchives of General Psychiatry, 2003
- Antidepressant efficacy of two different rTMS proceduresEuropean Archives of Psychiatry and Clinical Neuroscience, 2003